Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #64,251 to #64,300.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Murder-suicide (5 revisions)
  2. Muscarinic acetylcholine receptor M5 (5 revisions)
  3. Muscle weakness CT (5 revisions)
  4. Muscle weakness and Neuropathy (5 revisions)
  5. Muscle weakness case study one (5 revisions)
  6. Muscle weakness chest x ray (5 revisions)
  7. Muscle weakness cost-effectiveness of therapy (5 revisions)
  8. Muscle weakness epidemiology and demographics (5 revisions)
  9. Muscle weakness future or investigational therapies (5 revisions)
  10. Muscle weakness historical perspective (5 revisions)
  11. Muscle weakness other diagnostic studies (5 revisions)
  12. Muscle weakness other imaging findings (5 revisions)
  13. Muscle weakness physical examination (5 revisions)
  14. Muscle weakness primary prevention (5 revisions)
  15. Muscle weakness risk factors (5 revisions)
  16. Muscle weakness screening (5 revisions)
  17. Muscle weakness secondary prevention (5 revisions)
  18. Musculoskeletal problems of the wrist and hand classification (5 revisions)
  19. Musculoskeletal system (5 revisions)
  20. Mushroom poisoning (5 revisions)
  21. Myalgia differential diagnosis (5 revisions)
  22. Myalgia future or investigational therapies (5 revisions)
  23. Myasthenia gravis other imaging findings (5 revisions)
  24. Mycobacterium abscessus historical perspective (5 revisions)
  25. Mycobacterium abscessus other imaging findings (5 revisions)
  26. Mycobacterium abscessus risk factors (5 revisions)
  27. Mycobacterium avium intracellulare (5 revisions)
  28. Mycobacterium immunogenum (5 revisions)
  29. Mycosis fungoides case study one (5 revisions)
  30. Mycosis fungoides electrocardiogram (5 revisions)
  31. Myocarditis cost-effectiveness of therapy (5 revisions)
  32. Myoclonus natural history, complications and prognosis (5 revisions)
  33. Myofascial pain syndrome (5 revisions)
  34. Myopericarditis (5 revisions)
  35. Myopia physical examination (5 revisions)
  36. Myopia primary prevention (5 revisions)
  37. Myotonia congenita (5 revisions)
  38. Myxedema coma epidemiology and demographics (5 revisions)
  39. Myxedema coma primary prevention (5 revisions)
  40. Myxoma cost-effectiveness of therapy (5 revisions)
  41. Myxoma future or investigational therapies (5 revisions)
  42. N-Acetylaspartylglutamate (5 revisions)
  43. NAD+ kinase (5 revisions)
  44. NEXOBRID (5 revisions)
  45. NF-κB (5 revisions)
  46. NPM1 (5 revisions)
  47. NRF1 (5 revisions)
  48. Nadifloxacin (5 revisions)
  49. Naegleria infection causes (5 revisions)
  50. Naegleria infection cost-effectiveness of therapy (5 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)